However, the administration of endogenous agonists of AhR such as cinnabarinic acid (CA) down-regulated CD36 and reduced the uptake of free fatty acids in hepatocytes, thus achieving the inhibition of hepatic steatosis and liver injury (Patil et al., 2022). The gene discussed is CD36; the disease is fatty liver disease.